<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) October 1, 2000
GSI Lumonics Inc.
-----------------
(Exact Name of Registrant as Specified in Charter)
<TABLE>
<CAPTION>
<S> <C> <C>
New Brunswick, Canada 333-71449 N/A
---------------------------- ---------------- -----------------------------
(State or Other Juris- (Commission File (IRS Employer Identification
diction of Incorporation) Number) No.)
105 Schneider Road, Kanata, Ontario, Canada K2K1Y3
------------------------------------------- -----------------------------
(Zip Code)
(Address of Principal Executive Offices)
</TABLE>
Registrant's telephone number, including area code # (613) 592-1460
N/A
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 2. Acquisition or Disposition of Assets.
On Monday, October 2, 2000, the Company completed the sale of the assets of
its Life Sciences business which is involved in the design, development,
manufacture and marketing of microarray scanners, biochip arrayers, and
bioinformatics to Packard BioScience Company. The purchase price for the
business was U.S.$40 million in cash and approximately 4.6 million shares of
Packard common stock (with an adjustment based on a post-closing net worth
valuation).
Packard BioScience Company, located in Meriden, Connecticut, is a
developer, manufacturer and marketer of instruments and related consumables and
services for use in the life sciences research and nuclear industries. Packard
in the past has purchased products and services from the Company. The amount of
such purchases was $18,000 during 1999 and $24,000 to date during 2000.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(a) Financial Statements of Business Acquired:
Not applicable
(b) Pro Forma Financial Information:
Not applicable
(c) Exhibits:
Exhibit Description
2.1 Asset Purchase Agreement, dated as of August 19 , 2000 between GSI Lumonics
Life Science Trust, GSI Lumonics Trust, Inc. and Packard BioScience
Company.
99.1 Press release issued by GSI Lumonics Inc., dated October 2, 2000.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
GSI LUMONICS INC.
Date: October 16, 2000 By: /s/ Thomas R. Swain
______________________________
Name: Thomas R. Swain
Title: Vice President of Finance and
Chief Financial Officer
3
<PAGE>
EXHIBIT INDEX
The following exhibits are filed herewith.
Exhibit Description
2.1 Asset Purchase Agreement, dated as of August 19, 2000, between GSI
Lumonics Life Science Trust, GSI Lumonics Trust, Inc. and Packard
BioScience Company.
99.1 Press release issued by GSI Lumonics Inc., dated October 2, 2000.
4
